(Q53156805)
Statements
Tolerability-adapted imatinib 800 mg/d versus 400 mg/d versus 400 mg/d plus interferon-α in newly diagnosed chronic myeloid leukemia. (English)
Claudia Haferlach
1 reference
Alois Gratwohl
Rüdiger Hehlmann
Susanne Jung-Munkwitz
Armin Leitner
Martin C Müller
Nadine Pletsch
Ulrike Proetel
Brigitte Schlegelberger
Leopold Balleisen
Mathias Hänel
Markus Pfirrmann
Christoph Nerl
Hans Pralle
Dieter K Hossfeld
Joerg Hasford
Susanne Saussele
21 March 2011
29
12
1634-1642